Spyre Therapeutics Inc (NAS:SYRE)
$ 87.25 +0.17 (+0.2%) Market Cap: 7.69 Bil Enterprise Value: 6.69 Bil PE Ratio: 0 PB Ratio: 8.05 GF Score: 26/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1